E. M. GOLD, M.D.; J. R. KENT, M.D.; P. H. FORSHAM, M.D.
Disorders involving the adrenocortical secretion of cortisol have become more precisely characterized within recent years as knowledge concerning pituitary-adrenal physiology has increased and as newer, more critical means of study have become available. The secretion of cortisol by the adrenal cortex is normally regulated by corticotropin discharged from the anterior pituitary gland in response to stimuli from the ventral hypothalamus.1 A quantitative estimate of the adrenal component of this system became possible when various procedures employing corticotropin as a direct and specific stimulator of the adrenal cortices were developed.2, 3 For qualitatively demonstrating the extent of adrenocortical regulation by corticotropin,
Learn more about subscription options.
Register Now for a free account.
GOLD EM, KENT JR, FORSHAM PH. CLINICAL USE OF A NEW DIAGNOSTIC AGENT, METHOPYRAPONE (SU-4885), IN PITUITARY AND ADRENOCORTICAL DISORDERS(CLINICAL USE OF A NEW DIAGNOSTIC AGENT, METHOPYRAPONE (SU-4885), IN PITUITARY AND ADRENOCORTICAL DISORDERS*†)(CLINICAL USE OF A NEW DIAGNOSTIC AGENT, METHOPYRAPONE (SU-4885), IN PITUITARY AND ADRENOCORTICAL DISORDERS*†). Ann Intern Med. 1961;54:175–188. doi: 10.7326/0003-4819-54-2-175
Download citation file:
Published: Ann Intern Med. 1961;54(2):175-188.
Adrenal Disorders, Endocrine and Metabolism, Neurology, Pituitary Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only